Clinical trial
A Prospective, Non-Randomized, Multicenter, Single-Arm, Clinical Trial to Assess the Safety and Efficacy of the RX HERCULINK 14 Peripheral Stent System for Treatment in de Novo or Restenotic Renal Artery Stenosis
NCT00180544 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Non-Randomized, Multicenter, Single-Arm, Clinical Trial to Assess the Safety and Efficacy of the RX HERCULINK 14 Peripheral Stent System for Treatment in de Novo or Restenotic Renal Artery Stenosis
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2000
- Completion date
- August 31, 2004
- Enrollment
- 167 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.